Rapid and ultra-rapid metabolizers with CYP2C19 *17 polymorphism do not respond to standard therapy with proton pump inhibitors

Cytochrome P-450 Polymorphisms and Response to Clopidogrel

Jessica L. Mega, Sandra Close, Stephen D. Wiviott et al. · New England Journal of Medicine · 2008 · 2.5K citations · Full text

Medicine, Cardiology, Pharmacology +17

PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel

Yong Zhang, Meirong Huo, Jianping Zhou et al. · Computer Methods and Programs in Biomedicine · 2010 · 2.1K citations

Pharmacy, Pharmacokinetics, Pharmacology +7

Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study

Jean‐Philippe Collet, Jean‐Sébastien Hulot, Anna Pena et al. · The Lancet · 2008 · 966 citations

Medicine, Cardiology, Pharmacology +17

A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants

Sung Eun Sim, Carl Risinger, Eleni Aklillu et al. · Clinical Pharmacology & Therapeutics · 2006 · 729 citations

Medicine, Pharmacokinetics, Pharmacology +17

The Burden of Gastrointestinal and Liver Diseases, 2006

Nicholas J. Shaheen, Richard A. Hansen, Douglas R. Morgan et al. · The American Journal of Gastroenterology · 2006 · 700 citations

Medicine, Internal Medicine, Pharmacoeconomics +7